Dermaliq Therapeutics, Inc.
🇺🇸United States
Clinical Trials
5
Active:1
Completed:4
Trial Phases
1 Phases
Phase 1:4
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (4 trials with phase data)• Click on a phase to view related trials
Phase 1
4 (100.0%)Safety and Efficacy Study of Topical DLQ01 in the Treatment of Androgenetic Alopecia (AGA) in Men
Phase 1
Completed
- Conditions
- Androgenetic Alopecia
- Interventions
- Drug: prostaglandin F2a analogue in vehicle solution high doseDrug: prostaglandin F2a analogue in vehicle solution low doseDrug: active ingredient-free vehicle solution to DLQ01
- First Posted Date
- 2022-12-05
- Last Posted Date
- 2024-04-08
- Lead Sponsor
- Dermaliq Therapeutics, Inc.
- Target Recruit Count
- 120
- Registration Number
- NCT05636904
- Locations
- 🇦🇺
Dr Rodney Sinclair Pty Ltd,, Pascoe Vale South, Victoria, Australia
News
No news found